ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
5,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
6,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
7,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
7,2,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
7,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
7,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
7,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
7,6,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,Y
7,7,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
8,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
8,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
9,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
10,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
10,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
10,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
10,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10,5,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
10,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10,7,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
10,8,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
10,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
11,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
12,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
13,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
13,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
14,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
14,2,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
14,3,Headache,Headaches NEC,Headaches,Nerv,N
14,4,Optic ischaemic neuropathy,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
14,5,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
14,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
14,7,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
14,8,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
14,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
15,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
15,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
15,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
16,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
16,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
16,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
16,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
16,5,Pneumonia klebsiella,Klebsiella infections,Bacterial infectious disorders,Infec,N
16,6,Radiation pneumonitis,Radiation injuries,Injuries by physical agents,Inj&P,N
16,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
16,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
17,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
17,2,Optic ischaemic neuropathy,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
17,3,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
18,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
18,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
18,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
18,4,Skin fragility,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
19,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
19,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
19,3,Radiation pneumonitis,Radiation injuries,Injuries by physical agents,Inj&P,N
20,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
21,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
22,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
23,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
23,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
24,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
25,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
26,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
26,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
27,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
27,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
28,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
29,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,Y
30,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
31,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
31,2,Ocular myasthenia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
32,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
32,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
33,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
34,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
34,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
34,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
34,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
34,5,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
34,6,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
34,7,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
35,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
35,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
36,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
37,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
38,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
39,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
39,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
40,1,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
40,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
41,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
42,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
43,1,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
44,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
44,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
44,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
44,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
44,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
44,6,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
44,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
45,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
46,1,Coeliac disease,Malabsorption syndromes,Malabsorption conditions,Gastr,N
47,1,Encephalitis autoimmune,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,Y
48,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
49,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
50,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
51,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
52,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
53,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
54,1,Radiation pneumonitis,Radiation injuries,Injuries by physical agents,Inj&P,N
55,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
55,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
55,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
55,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
56,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
57,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
57,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
58,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
59,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
59,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
60,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
60,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
60,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
61,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
62,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
62,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
63,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
64,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
65,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
66,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
67,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
68,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
68,2,Radiation pneumonitis,Radiation injuries,Injuries by physical agents,Inj&P,N
69,1,Immune-mediated dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
69,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
70,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
70,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
71,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
71,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
71,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
72,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
72,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
72,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
73,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
73,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
74,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
74,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
74,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
74,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
74,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
74,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
74,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
75,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
76,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
77,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
78,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
79,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
80,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
81,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,Y
82,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
83,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
84,1,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
85,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
86,1,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
87,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
87,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
87,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
88,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
88,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
89,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
90,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,Y
91,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
92,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
93,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
94,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
94,2,Lung squamous cell carcinoma stage III,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
94,3,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
94,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
94,5,Normochromic normocytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
94,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
94,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
94,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
95,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
95,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
96,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
97,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
98,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
98,3,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
99,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
99,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
99,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
100,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
101,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
102,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
102,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
103,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
103,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
103,4,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
103,5,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
103,6,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
103,7,Oesophageal spasm,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
103,8,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
103,9,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
104,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,Y
105,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
106,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
107,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
108,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
109,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
110,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
111,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
111,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
111,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
112,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
112,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
113,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
113,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
114,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
115,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
116,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
117,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
118,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
119,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
119,2,Lung adenocarcinoma recurrent,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
119,3,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
119,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
120,1,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
121,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
121,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
121,3,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
121,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
121,5,Radiation pneumonitis,Radiation injuries,Injuries by physical agents,Inj&P,N
122,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
122,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
123,1,Bladder neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
124,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
125,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
125,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
126,1,Fat embolism,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
126,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
127,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
127,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
128,1,Catarrh,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
128,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
128,3,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
128,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
128,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
129,1,Blood thyroid stimulating hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
129,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
129,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
129,4,Radiation pneumonitis,Radiation injuries,Injuries by physical agents,Inj&P,N
130,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
130,2,Henoch-Schonlein purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
130,3,Neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
130,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
131,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
132,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
132,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
132,3,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
132,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
133,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
134,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
135,1,Ocular myasthenia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
136,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
137,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
138,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
138,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
138,3,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
139,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
140,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
140,2,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
